Literature DB >> 32451957

Posterolateral lumbar spine fusion with unidirectional porous beta-tricalcium phosphate in a canine model.

Kosuke Sato1, Hiroshi Kumagai2, Toru Funayama1, Tomokazu Yoshioka1, Yosuke Shibao1, Kentaro Mataki1, Katsuya Nagashima1, Kousei Miura1, Hiroshi Noguchi1, Tetsuya Abe1, Masao Koda1, Masashi Yamazaki1.   

Abstract

We investigated the use of the autologous iliac bone and unidirectional porous beta-tricalcium phosphate (UDPTCP) in posterolateral lumbar spine fusion (PLF). Ten canine PLF models were prepared. Using only the autologous bone as the control group, 100%, 75%, 50%, and 25% groups were prepared according to the mixing ratios of UDPTCP. Radiological evaluation and histological analysis were performed 12 weeks after surgery. Bone fusion was evaluated according to anteroposterior plain X-rays and coronal reconstruction CT views using four grades: 0 = no osteogenesis, 1 = only slight discontinuous osteogenesis between transverse processes, 2 = discontinuous osteogenesis between transverse processes, and 3 = continuous osteogenesis between transverse processes. Bone fusion determined by X-ray was 2.8 ± 0.5 in the control group, 0 in the 100% UDPTCP group (p = 0.02), 1.8 ± 0.5 (p = 0.03) in the 75% UDPTCP group, 2.5 ± 0.6 (p = 0.54) in the 50% UDPTCP group, and 2.8 ± 0.5 (p = 1.0) in the 25% UDPTCP group. The bone fusion score was significantly lower in the 75% and 100% UDPTCP groups than in the control group. Bone fusion determined by CT was 2.8 ± 0.5 in the control group, 1.0 ± 0.8 (p = 0.01) in the 100% UDPTCP group, 2.0 ± 0.0 (p = 0.02) in the 75% UDPTCP group, 2.5 ± 0.6 (p = 0.54) in the 50% UDPTCP group, and 2.8 ± 0.5 (p = 1.0) in the 25% UDPTCP group. Similar to the bone fusion determination by X-ray, the bone fusion score was significantly lower in the 75% and 100% UDPTCP groups. These data suggest that, in a canine PLF model, the appropriate mixing ratio of UDPTCP is 50% or less.

Entities:  

Keywords:  Canine model; Posterolateral lumbar spine fusion; Unidirectional porous beta-tricalcium phosphate

Mesh:

Substances:

Year:  2020        PMID: 32451957     DOI: 10.1007/s10047-020-01178-9

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  2 in total

1.  A Pre-clinical Standard Operating Procedure for Evaluating Orthobiologics in an In Vivo Rat Spinal Fusion Model.

Authors:  Andrew L Alejo; Scott McDermott; Yusuf Khalil; Hope C Ball; Gabrielle T Robinson; Ernesto Solorzano; Amanda M Alejo; Jacob Douglas; Trinity K Samson; Jesse W Young; Fayez F Safadi
Journal:  J Orthop Sports Med       Date:  2022-09-05

Review 2.  Unidirectional porous beta-tricalcium phosphate and hydroxyapatite artificial bone: a review of experimental evaluations and clinical applications.

Authors:  Toru Funayama; Hiroshi Noguchi; Hiroshi Kumagai; Kosuke Sato; Tomokazu Yoshioka; Masashi Yamazaki
Journal:  J Artif Organs       Date:  2021-04-23       Impact factor: 1.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.